Phys/Pharm lecture: David Mangelsdorf, PhD – Feb. 23

David J. Mangelsdorf, Ph.D., Chair of the Department of Pharmacology and Distinguished Chair in Biomedical Sciences at the University of Texas Southwestern Medical Center, ushered in the era of orphan nuclear hormone receptor research. His findings revealed the long sought-after mechanism by which the body senses and disposes of excess cholesterol.

Dr. Mangelsdorf’s research has led to unexpected insights into human disease and will be the focus of his upcoming Phys/Pharm Louis S. Goodman lecture, “Nuclear Receptors, Fibroblast Growth Factors (FGFs), and Metabolism.” The lecture will be held Thursday, February 23, 2012, from 4 to 5 p.m. in the Medical Student Lecture Hall, Room 4320, Richard Jones Hall.

Bookmark and Share

Comments are closed.

About the Author

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Read more

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives